Ginsenosides chemistry, biosynthesis, analysis, and potential health effects.

Ginsenosides are a special group of triterpenoid saponins that can be classified into two groups by the skeleton of their aglycones, namely dammarane- and oleanane-type. Ginsenosides are found nearly exclusively in Panax species (ginseng) and up to now more than 150 naturally occurring ginsenosides have been isolated from roots, leaves/stems, fruits, and/or flower heads of ginseng. Ginsenosides have been the target of a lot of research as they are believed to be the main active principles behind the claims of ginsengs efficacy. The potential health effects of ginsenosides that are discussed in this chapter include anticarcinogenic, immunomodulatory, anti-inflammatory, antiallergic, antiatherosclerotic, antihypertensive, and antidiabetic effects as well as antistress activity and effects on the central nervous system. Ginsensoides can be metabolized in the stomach (acid hydrolysis) and in the gastrointestinal tract (bacterial hydrolysis) or transformed to other ginsenosides by drying and steaming of ginseng to more bioavailable and bioactive ginsenosides. The metabolization and transformation of intact ginsenosides, which seems to play an important role for their potential health effects, are discussed. Qualitative and quantitative analytical techniques for the analysis of ginsenosides are important in relation to quality control of ginseng products and plant material and for the determination of the effects of processing of plant material as well as for the determination of the metabolism and bioavailability of ginsenosides. Analytical techniques for the analysis of ginsenosides that are described in this chapter are thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC) combined with various detectors, gas chromatography (GC), colorimetry, enzyme immunoassays (EIA), capillary electrophoresis (CE), nuclear magnetic resonance (NMR) spectroscopy, and spectrophotometric methods.

[1]  M. Simmonds,et al.  Liquid chromatography/mass spectrometry of malonyl-ginsenosides in the authentication of ginseng. , 2003, Rapid communications in mass spectrometry : RCM.

[2]  I. Saiki,et al.  Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. , 2000, Biological & pharmaceutical bulletin.

[3]  J. Auwerx,et al.  Regulation of apo A-I gene expression by fibrates. , 1997, Atherosclerosis.

[4]  H. Matsuda,et al.  Medicinal flowers. XVI. New dammarane-type triterpene tetraglycosides and gastroprotective principles from flower buds of Panax ginseng. , 2007, Chemical & pharmaceutical bulletin.

[5]  N. Baek,et al.  Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. , 1996, Planta medica.

[6]  S. Ebbs,et al.  Simplified extraction of ginsenosides from American ginseng (Panax quinquefolius L.) for high-performance liquid chromatography-ultraviolet analysis. , 2005, Journal of agricultural and food chemistry.

[7]  K. Kawazoe,et al.  New dammarane-type saponin from roots of Panax notoginseng , 2006, Journal of Natural Medicines.

[8]  F. Song,et al.  Metal ion adducts in the structural analysis of ginsenosides by electrospray ionization with multi-stage mass spectrometry. , 2001, Rapid communications in mass spectrometry : RCM.

[9]  P. Eneroth,et al.  Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng. , 1996, Scandinavian journal of clinical and laboratory investigation.

[10]  J. Kim,et al.  Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. , 2005, Journal of pharmacological sciences.

[11]  S. Kwon,et al.  Three new dammarane glycosides from heat processed ginseng , 2002, Archives of pharmacal research.

[12]  R. Wills,et al.  Changes in neutral and malonyl ginsenosides in American ginseng (Panax quinquefolium) during drying, storage and ethanolic extraction , 2004 .

[13]  M. Kubo,et al.  Histochemistry. I. Ginsenosides in Ginseng (Panax ginseng C. A. Meyer, Root) , 1980 .

[14]  Guangji Wang,et al.  Simultaneous determination of panax notoginsenoside R1, ginsenoside Rg1, Rd, Re and Rb1 in rat plasma by HPLC/ESI/MS: platform for the pharmacokinetic evaluation of total panax notoginsenoside, a typical kind of multiple constituent traditional Chinese medicine. , 2007, Biomedical chromatography : BMC.

[15]  S. Yahara,et al.  Further study on dammarane-type saponins of roots, leaves, flower-buds, and fruits of Panax ginseng C.A. Meyer , 1979 .

[16]  Jinlan Zhang,et al.  Liquid chromatographic method for determination of four active saponins from Panax notoginseng in rat urine using solid-phase extraction. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  T. M. Lee,et al.  Two-dimensional TLC analysis of ginsenosides from root of dwarf ginseng (Panax trifolius L.) Araliaceae. , 1981, Journal of pharmaceutical sciences.

[18]  J. A. Wood,et al.  Extraction of ginsenosides from North American ginseng using modified supercritical carbon dioxide , 2006 .

[19]  D. Choi,et al.  Analysis of transcripts in methyl jasmonate-treated ginseng hairy roots to identify genes involved in the biosynthesis of ginsenosides and other secondary metabolites , 2004, Plant Cell Reports.

[20]  Y. Ebizuka,et al.  Dammarenediol‐II synthase, the first dedicated enzyme for ginsenoside biosynthesis, in Panax ginseng , 2006, FEBS letters.

[21]  Lawrence A Leiter,et al.  American Ginseng Improves Glycemia in Individuals with Normal Glucose Tolerance: Effect of Dose and Time Escalation , 2000, Journal of the American College of Nutrition.

[22]  J. Hendel,et al.  Reversed-phase high-performance liquid chromatography determination of ginsenosides of Panax quinquefolium , 1996 .

[23]  M. Meselhy,et al.  Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells. , 2002, Japanese journal of pharmacology.

[24]  Deok-Chun Yang,et al.  Enhanced triterpene and phytosterol biosynthesis in Panax ginseng overexpressing squalene synthase gene. , 2004, Plant & cell physiology.

[25]  P. Zarzycki,et al.  Isocratic separation of ginsenosides by high-performance liquid chromatography on a diol column at subambient temperatures , 2006, Analytical and bioanalytical chemistry.

[26]  M. Gershwin,et al.  Quantitative determination of ginsenosides by high-performance liquid chromatography-tandem mass spectrometry. , 2001, Phytochemical analysis : PCA.

[27]  Ming-zhu Wu,et al.  Dammarane-Saponins of Sanchi-Ginseng, Roots of Panax notoginseng (BURK.) F.H. CHEN (Araliaceae) : Structures of New Saponins, Notoginsenosides-R1 and -R2, and Identification of Ginsenosides-Rg2 and -Rh1 , 1981 .

[28]  P. Shashidharan,et al.  Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson’s disease , 2000, Journal of Neurology.

[29]  Tai-Ping Fan,et al.  Angiogenesis: from plants to blood vessels. , 2006, Trends in pharmacological sciences.

[30]  S. Kwon,et al.  Cytotoxic dammarane glycosides from processed ginseng. , 2002, Chemical & pharmaceutical bulletin.

[31]  M. Schubert-Zsilavecz,et al.  Degradation of ginsenosides in humans after oral administration. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[32]  Motomasa Kobayashi,et al.  Inhibition of in vitro Tumor Cell Invasion by Ginsenoside Rg3 , 1996, Japanese journal of cancer research : Gann.

[33]  Yuan-Shiun Chang,et al.  Microwave-assisted extraction of ginsenosides from ginseng root , 2003 .

[34]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[35]  F. Gonzalez,et al.  Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha. , 2006, Biochemical and biophysical research communications.

[36]  A. Osbourn,et al.  Biosynthesis of triterpenoid saponins in plants. , 2002, Advances in biochemical engineering/biotechnology.

[37]  T. Yun Panax ginseng--a non-organ-specific cancer preventive? , 2001, The Lancet. Oncology.

[38]  S. Kadota,et al.  Triterpenoid Saponins from Leaves and Stems of Panax Quinquefolium L , 2001, Journal of Asian natural products research.

[39]  K. Jinno,et al.  Simultaneous LC Determination of Ginsenosides Using a Modified Extraction Procedure and an Improved Step Gradient Program , 2006 .

[40]  Y. Shoyama,et al.  Western blotting for ginseng saponins, ginsenosides using anti-ginsenoside Rb1 monoclonal antibody. , 1999, Biological & pharmaceutical bulletin.

[41]  Yiyu Cheng,et al.  Solid-phase extraction and liquid chromatography-electrospray mass spectrometric analysis of saponins in a Chinese patent medicine of formulated Salvia miltiorrhizae and Panax notoginseng. , 2006, Journal of pharmaceutical and biomedical analysis.

[42]  S. Kao,et al.  INCREASE OF INSULIN SECRETION BY GINSENOSIDE RH2 TO LOWER PLASMA GLUCOSE IN WISTAR RATS , 2006, Clinical and experimental pharmacology & physiology.

[43]  Y. Hahn,et al.  Discovery of genes for ginsenoside biosynthesis by analysis of ginseng expressed sequence tags , 2003, Plant Cell Reports.

[44]  C. Benishin Actions of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings , 1992, Neurochemistry International.

[45]  L. Freedman,et al.  Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy , 2006, Trends in Endocrinology & Metabolism.

[46]  J. Fitzloff,et al.  HPLC DETERMINATION OF GINSENOSIDES CONTENT IN GINSENG DIETARY SUPPLEMENTS USING ULTRAVIOLET DETECTION , 2002 .

[47]  M. Choo,et al.  Antiallergic activity of ginsenoside Rh2. , 2003, Biological & pharmaceutical bulletin.

[48]  Zhenjiang Zhao,et al.  Efficient induction of ginsenoside biosynthesis and alteration of ginsenoside heterogeneity in cell cultures of Panax notoginseng by using chemically synthesized 2-hydroxyethyl jasmonate , 2006, Applied Microbiology and Biotechnology.

[49]  S. Nah,et al.  Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. , 2002, Biochemical and biophysical research communications.

[50]  D. Moon,et al.  Determination of a Ginseng Saponin Metabolite, IH901, in Rat Plasma by Liquid Chromatography‐Tandem Mass Spectrometry , 2005 .

[51]  R. Kasai,et al.  Saponins of Zu-Tziseng, Rhizomes of Panax japonicus C.A. MEYER var. major (BURK.) C.Y. Wu et K.M. FENG, collected in Yunnan, China , 1982 .

[52]  S. Yahara,et al.  Dammarane type saponins of leaves of Panax japonicus C.A. Meyer. (2). Saponins of the specimens collected in Tottori-ken, Kyoto-shi, and Niigata-ken , 1978 .

[53]  Y. Shoyama,et al.  Monoclonal antibodies against naturally occurring bioactive compounds , 2004, Cytotechnology.

[54]  H. Matsuda,et al.  Medicinal flowers. XI. Structures of new dammarane-type triterpene diglycosides with hydroperoxide group from flower buds of Panax ginseng. , 2007, Chemical & pharmaceutical bulletin.

[55]  Y. Shoyama,et al.  Formation of monoclonal antibody against a major ginseng component, ginsenoside Rb1 and its characterization , 2004, Cytotechnology.

[56]  S. Navarro,et al.  Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells. , 2006, Journal of ethnopharmacology.

[57]  Y. Lee,et al.  Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. , 1999, European journal of cancer.

[58]  V. Schini-Kerth,et al.  Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. , 1995, Life sciences.

[59]  I. Kitagawa,et al.  生薬修治の化学的解明(第1報)紅参(Ginseng Radix Rubra)の含有成分 その1 , 1983 .

[60]  Jae-Kwan Hwang,et al.  Ginsenoside 20(S)-Protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes , 2006 .

[61]  Lawrence A Leiter,et al.  Null and Opposing Effects of Asian Ginseng (Panax ginseng C.A. Meyer) on Acute Glycemia: Results of Two Acute Dose Escalation Studies , 2003, Journal of the American College of Nutrition.

[62]  Byung-Hwan Lee,et al.  Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats , 2005, Neuropharmacology.

[63]  J. Wan,et al.  A rapid HPLC-ESI-MS/MS for qualitative and quantitative analysis of saponins in "XUESETONG" injection. , 2006, Journal of pharmaceutical and biomedical analysis.

[64]  Cheng Yiyu,et al.  Analysis of 'SHENMAI' injection by HPLC/MS/MS. , 2003, Journal of pharmaceutical and biomedical analysis.

[65]  B. Gabetta,et al.  Determination of ginsenosides in Panax ginseng roots by liquid chromatography with evaporative light-scattering detection. , 2000, Journal of AOAC International.

[66]  U. Kintscher,et al.  Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity. , 2005, Diabetes.

[67]  I. Saiki,et al.  In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. , 1997, Oncology research.

[68]  Hwee-Ling Koh,et al.  Ultra-performance liquid chromatography/time-of-flight mass spectrometry based metabolomics of raw and steamed Panax notoginseng. , 2007, Rapid communications in mass spectrometry : RCM.

[69]  W. Rausch,et al.  Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate , 2004, Brain Research.

[70]  K. Jinno,et al.  Solid-Phase Extraction and High-Performance Liquid Chromatography for Simultaneous Determination of Important Bioactive Ginsenosides in Pharmaceutical Preparations , 2005 .

[71]  T. Hayashi,et al.  Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. I. Quantitative analysis of ginsenoside Rg1 in rats. , 1982, Chemical & pharmaceutical bulletin.

[72]  F. Song,et al.  Detection of saponins in extract of Panax notoginseng by liquid chromatography–electrospray ionisation-mass spectrometry , 2005 .

[73]  S. Kwon,et al.  Four new acetylated ginsenosides from processed ginseng (sun ginseng) , 2002, Archives of pharmacal research.

[74]  Xiao-ru Wang,et al.  Development of a quality evaluation system for Panax quinquefolium. L based on HPLC chromatographic fingerprinting of seven major ginsenosides , 2007 .

[75]  Jeong-Hill Park,et al.  High Performance Liquid Chromatographic Determination of Ginsenosides Using Photoreduction Fluorescence Detection , 1995 .

[76]  M. Birnbaum,et al.  Role of AMP-activated Protein Kinase in Cyclic AMP-dependent Lipolysis In 3T3-L1 Adipocytes* , 2003, Journal of Biological Chemistry.

[77]  Guangji Wang,et al.  Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction. , 2005, Journal of pharmaceutical and biomedical analysis.

[78]  S. I. Kim,et al.  Platelet activating factor antagonist activity of ginsenosides. , 1998, Biological & pharmaceutical bulletin.

[79]  H. Chung,et al.  Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. , 1999, International journal of oncology.

[80]  Guangji Wang,et al.  Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats. , 2007, Biological & pharmaceutical bulletin.

[81]  J. Zhong,et al.  Purification and characterization of UDPG:ginsenoside Rd glucosyltransferase from suspended cells of Panax notoginseng , 2005 .

[82]  J. Shoji,et al.  Studies on the Constituents of Panacis Japonici Rhizoma. IV. The Structure of Chikusetsusaponin V , 1970 .

[83]  Ji Ming Wang,et al.  Differential effects of ginsenosides on NO and TNF-α production by LPS-activated N9 microglia , 2007 .

[84]  P. Eneroth,et al.  Analysis of ginsenosides by chromatography and mass spectrometry: release of 20 S-protopanaxadiol and 20 S-protopanaxatriol for quantitation. , 1993, Analytical biochemistry.

[85]  U. Otten,et al.  Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials , 1997, Progress in Neurobiology.

[86]  B. H. Ren,et al.  Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide , 2001, British journal of pharmacology.

[87]  H. Suh,et al.  Inhibition of stress‐induced plasma corticosterone levels by ginsenosides in mice: involvement of nitric oxide , 1998, Neuroreport.

[88]  K. Haruta,et al.  Effects of ginsenosides on impaired performance induced in the rat by scopolamine in a radial-arm maze , 1995, Psychoneuroendocrinology.

[89]  Katsuko Komatsu,et al.  Dammarane-type Saponins from Panax japonicus and their neurite outgrowth activity in SK-N-SH cells. , 2002, Journal of natural products.

[90]  C. N. Gillis,et al.  Panax ginseng pharmacology: a nitric oxide link? , 1997, Biochemical pharmacology.

[91]  Dong Hwan Sohn,et al.  A ginsenoside metabolite, 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol, triggers apoptosis in activated rat hepatic stellate cells via caspase-3 activation. , 2006, Planta medica.

[92]  D. Dou,et al.  Six new dammarane-type triterpene saponins from the leaves of Panax ginseng. , 2001, Chemical & pharmaceutical bulletin.

[93]  H. Neychev,et al.  Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. , 1990, Japanese journal of pharmacology.

[94]  S. Sanada,et al.  Studies on the saponins of ginseng. III. Structures of ginsenoside-Rb3 and 20-glucoginsenoside-Rf. , 1978 .

[95]  B. Buszewski,et al.  Isolation and determination of ginsenosides in American ginseng leaves and root extracts by LC-MS , 2005, Analytical and bioanalytical chemistry.

[96]  H. Matsuda,et al.  Bioactive saponins and glycosides. XIX. Notoginseng (3): immunological adjuvant activity of notoginsenosides and related saponins: structures of notoginsenosides-L, -M, and -N from the roots of Panax notoginseng (Burk.) F. H. Chen. , 2001, Chemical & pharmaceutical bulletin.

[97]  O. Sticher Getting to the Root of Ginseng , 1998 .

[98]  N. Fuzzati Analysis methods of ginsenosides. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[99]  C. Yang,et al.  Dammarane saponins from Panax ginseng. , 1995, Phytochemistry.

[100]  C. Benishin,et al.  Effects of ginsenoside Rb1 on central cholinergic metabolism. , 1991, Pharmacology.

[101]  O. Tanaka,et al.  Panax ginseng: Relation between Age of Plant and Content of Ginsenosides. , 1984, Planta medica.

[102]  Hee-Sun Kim,et al.  Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. , 2006, Planta medica.

[103]  P. Xiao,et al.  Recent advances on ginseng research in China. , 1992, Journal of ethnopharmacology.

[104]  H. Kang,et al.  Ginsenoside‐Rh1 and Rh2 inhibit the induction of nitric oxide synthesis in murine peritoneal macrophages , 1996, Biochemistry and molecular biology international.

[105]  S. Sheu,et al.  Determination of ginsenosides in ginseng crude extracts by high-performance liquid chromatography , 1994 .

[106]  H. Kobayashi,et al.  Effects of ginsenosides on impaired performance caused by scopolamine in rats. , 1996, European journal of pharmacology.

[107]  Hui Wang,et al.  In vitro anti-cancer activity and structure–activity relationships of natural products isolated from fruits of Panax ginseng , 2007, Cancer Chemotherapy and Pharmacology.

[108]  E. Asafu-Adjaye,et al.  Determination of ginsenosides (ginseng saponins) in dry root powder from Panax ginseng, Panax quinquefolius, and selected commercial products by liquid chromatography: interlaboratory study. , 2003, Journal of AOAC International.

[109]  I. Nagata,et al.  Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells , 1998, Japanese journal of cancer research : Gann.

[110]  N. D. Kim,et al.  Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. , 1994, General pharmacology.

[111]  J. Zhong,et al.  Enhancement of ginsenoside biosynthesis in high-density cultivation of Panax notoginseng cells by various strategies of methyl jasmonate elicitation , 2005, Applied Microbiology and Biotechnology.

[112]  B. Gabetta,et al.  Gas-liquid chromatographic method for determination of ginsenosides in Panax ginseng. , 1980 .

[113]  Y. Oh,et al.  Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. , 1997, Cancer letters.

[114]  S. Kim,et al.  The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. , 2006, Pharmacological research.

[115]  O. Tanaka,et al.  Studies on the saponins of ginseng. II. Structures of ginsenoside-Re, -Rf and -Rg2. , 1974 .

[116]  F. Shimada,et al.  Studies on the enzyme immunoassay of bio-active constituents in oriental medicinal drugs. VI. Enzyme immunoassay of ginsenoside Rb1 from Panax ginseng. , 1992, Chemical & pharmaceutical bulletin.

[117]  Chuanshe Wang,et al.  HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies. , 2004, Biomedical chromatography : BMC.

[118]  H. Yeung,et al.  Ginseng Saponins: Influence on Neurotransmitter Uptake in Rat Brain Synaptosomes , 1985, Planta medica.

[119]  T. Larsen,et al.  PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? , 2003, International Journal of Obesity.

[120]  Y. Choi,et al.  Application of Two-Dimensional Nuclear Magnetic Resonance Spectroscopy to Quality Control of Ginseng Commercial Products , 2006, Planta medica.

[121]  Katsuaki Sato,et al.  Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. , 1994, Biological & pharmaceutical bulletin.

[122]  W. Li,et al.  A new saponin from the leaves and stems of Panax quinquefolium L. collected in Canada. , 1998, Journal of Asian natural products research.

[123]  J. Cho,et al.  In vitro inhibitory effect of protopanaxadiol Ginsenosides on tumor necrosis factor (TNF)-α production and its modulation by known TNF-α antagonists , 2001 .

[124]  Hideshi Kobayashi,et al.  Effects of oral and intraventricular administration of ginsenoside Rg1on the performance impaired by scopolamine in rats , 1996 .

[125]  S. Shibata,et al.  Pharmacological studies of Panacis Japonici Rhizoma. I. , 1977, Chemical & pharmaceutical bulletin.

[126]  S. Xu,et al.  Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. , 2000, Life sciences.

[127]  Y. Takino,et al.  Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. III. The absorption, distribution and excretion of ginsenoside Rb1 in the rat. , 1983, Chemical & pharmaceutical bulletin.

[128]  J. H. Oh,et al.  Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway. , 1999, Life sciences.

[129]  R. Kasai,et al.  Saponins from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. collected in central Vietnam. III. , 1994, Chemical & pharmaceutical bulletin.

[130]  S. Kim,et al.  Ginsenosides Rb1and Rg3protect cultured rat cortical cells from glutamate‐induced neurodegeneration , 1998, Journal of neuroscience research.

[131]  B. Oh,et al.  Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. , 2000, The American journal of Chinese medicine.

[132]  N. Murakami,et al.  Bioactive saponins and glycosides. VIII. Notoginseng (1): new dammarane-type triterpene oligoglycosides, notoginsenosides-A, -B, -C, and -D, from the dried root of Panax notoginseng (Burk.) F.H. Chen. , 1997, Chemical & pharmaceutical bulletin.

[133]  R. Kasai,et al.  Chemical and morphological study on Chinese Panax japonicus C. A. Meyer (Zhujie-Shen) , 1983 .

[134]  M. Choo,et al.  Antiallergic activity of ginseng and its ginsenosides. , 2003, Planta medica.

[135]  T. Ohsawa,et al.  Chemical studies on oriental plant drugs. XIV. Protopanaxadiol, a genuine sapogenin of ginseng saponins. , 1966, Chemical & pharmaceutical bulletin.

[136]  S. Nah,et al.  Evidence that the tertiary structure of 20(S)-ginsenoside Rg(3) with tight hydrophobic packing near the chiral center is important for Na(+) channel regulation. , 2005, Biochemical and biophysical research communications.

[137]  Y. Kimura,et al.  Effects of Various Ginseng Saponins on 5‐Hydroxytryptamine Release and Aggregation in Human Platelets , 1988, The Journal of pharmacy and pharmacology.

[138]  S. Nah,et al.  Determination of ginsenoside Rf and Rg2 from Panax ginseng using enzyme immunoassay. , 1998, Chemical & pharmaceutical bulletin.

[139]  H. Kobayashi,et al.  Effects of ginsenosides on maze performance and brain choline acetyltransferase activity in scopolamine-treated young rats and aged rats. , 1997, European journal of pharmacology.

[140]  R. Kasai,et al.  Saponins of buds and flowers of Panax ginseng C.A. Meyer. (1). Isolation of ginsenosides Rd, Re, and Rg1 , 1976 .

[141]  S. Chung,et al.  Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice , 2001, Archives of pharmacal research.

[142]  J. Wan,et al.  Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD. , 2007, Journal of separation science.

[143]  I. Saiki,et al.  Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. , 2002, Biological & pharmaceutical bulletin.

[144]  A. Bilia,et al.  NMR spectroscopy: a useful tool for characterisation of plant extracts, the case of supercritical CO2 arnica extract. , 2002, Journal of pharmaceutical and biomedical analysis.

[145]  Lawrence A Leiter,et al.  Decreasing, Null and Increasing Effects of Eight Popular Types of Ginseng on Acute Postprandial Glycemic Indices in Healthy Humans: The Role of Ginsenosides , 2004, Journal of the American College of Nutrition.

[146]  Yuan-jiang Pan,et al.  Immunological‐Adjuvant Saponins from the Roots of Panax notoginseng , 2005, Chemistry & biodiversity.

[147]  P. But,et al.  Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS. , 2000, Analytical chemistry.

[148]  D. Burney,et al.  Validation of sample preparation procedures for botanical analysis , 1998 .

[149]  A. Ludwiczuk,et al.  Chromatographic Analysis of Ginsenosides Occurring in the Roots of American Ginseng (Panax quinquefolium L.) and in Asian Ginseng (Panax ginseng C.A. Mayer) Preparations , 2002, JPC – Journal of Planar Chromatography – Modern TLC.

[150]  J. Sung,et al.  Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. , 1999, Cancer letters.

[151]  Q. Huang,et al.  Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. , 1994, Neuroimmunomodulation.

[152]  J. Wan,et al.  Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. , 2006, Journal of pharmaceutical and biomedical analysis.

[153]  I. Nagata,et al.  Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice , 2005, Journal of Cancer Research and Clinical Oncology.

[154]  Khaled Radad,et al.  Use of ginseng in medicine with emphasis on neurodegenerative disorders. , 2006, Journal of pharmacological sciences.

[155]  S. Ko,et al.  Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in icr mice , 2004, Archives of pharmacal research.

[156]  A. Rautio,et al.  Ginseng Therapy in Non-Insulin-Dependent Diabetic Patients: Effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight , 1995, Diabetes Care.

[157]  K. Polonsky,et al.  Ginseng berry reduces blood glucose and body weight in db/db mice. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[158]  J. Fitzloff,et al.  HPLC ANALYSIS OF GINSENOSIDES IN THE ROOTS OF ASIAN GINSENG (PANAX GINSENG) AND NORTH AMERICAN GINSENG (PANAX QUINQUEFOLIUS) WITH IN-LINE PHOTODIODE ARRAY AND EVAPORATIVE LIGHT SCATTERING DETECTION , 2002 .

[159]  S. Joo,et al.  Reciprocal Activity of Ginsenosides in the Production of Proinflammatory Repertoire, and their Potential Roles in Neuroprotection in vitro , 2005, Planta medica.

[160]  C. Benishin,et al.  Neurotrophic and Neuroprotective Actions of Ginsenosides Rb1 and Rg1 , 2001, Planta medica.

[161]  O. Tanaka,et al.  Studies on the Saponins of Ginseng. I. Structures of Ginsenoside-Ro, -Rb1, -Rb2, -Rc and -Rd , 1974 .

[162]  Ki-Ho Cho,et al.  Fecal metabolic activities of herbal components to bioactive compounds , 2002, Archives of pharmacal research.

[163]  S. O’Rahilly,et al.  PPARγ and human metabolic disease , 2006 .

[164]  N. D. Kim,et al.  Steaming of ginseng at high temperature enhances biological activity. , 2000, Journal of natural products.

[165]  Hongbin Xiao,et al.  Identification of Ginsenosides in Panax quinquefolium by LC-MS , 2006 .

[166]  M. Kobori,et al.  Effect of Ginsenosides and Red Ginseng Water Extract on Tumor Necrosis Factor-α Production by Rat Peritoneal Macrophages , 2002 .

[167]  D. Kim,et al.  Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. , 2000, Biological & pharmaceutical bulletin.

[168]  K. Zou,et al.  Comparative study on triterpene saponins of Ginseng drugs. , 2004, Planta medica.

[169]  H. Suh,et al.  Inhibition of intracerebroventricular injection stress-induced plasma corticosterone levels by intracerebroventricularly administered compound K, a ginseng saponin metabolite, in mice. , 2003, Biological & pharmaceutical bulletin.

[170]  D. Kitts,et al.  Generation of ginsenosides Rg3 and Rh2 from North American ginseng. , 2004, Phytochemistry.

[171]  H. Wagner,et al.  Economic and Medicinal Plant Research , 1988 .

[172]  Ying-hua Jin,et al.  Caspase 3-mediated Cleavage of p21 WAF1/CIP1 Associated with the Cyclin A-Cyclin-dependent Kinase 2 Complex Is a Prerequisite for Apoptosis in SK-HEP-1 Cells* , 2000, The Journal of Biological Chemistry.

[173]  U. Kidmose,et al.  Simultaneous determination of ginsenosides and polyacetylenes in American ginseng root (Panax quinquefolium L.) by high-performance liquid chromatography. , 2006, Journal of agricultural and food chemistry.

[174]  M. Kubo,et al.  Histochemistry II. Ginsenosides in Ginseng (Panax ginseng, Root) , 1981 .

[175]  T K Yun,et al.  Brief introduction of Panax ginseng C.A. Meyer. , 2001, Journal of Korean medical science.

[176]  L. Wang,et al.  Effect of ginseng saponins on beta-amyloid-suppressed acetylcholine release from rat hippocampal slices. , 2001, Planta medica.

[177]  G. Blaschke,et al.  Determination of ginsenosides from Panax ginseng using micellar electrokinetic chromatography. , 2002, Planta medica.

[178]  G. Eisenbrand,et al.  Panax notoginseng (Burk.) F. H. Chen , 1992 .

[179]  R. DeFronzo,et al.  Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. , 2004, The Journal of clinical endocrinology and metabolism.

[180]  Jeong-Hill Park,et al.  High-performance liquid chromatographic analysis of ginseng saponins using evaporative light scattering detection , 1996 .

[181]  J. Sung,et al.  Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. , 2000, Biochemical pharmacology.

[182]  Sugaya Eiichi,et al.  Proliferative effect of ginseng saponin on neurite extension of primary cultured neurons of the rat cerebral cortex. , 1988 .

[183]  I. Nagata,et al.  Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo , 1991, Anti-cancer drugs.

[184]  Chong-Zhi Wang,et al.  Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. , 2006, Journal of agricultural and food chemistry.

[185]  B. Blagg,et al.  Recombinant squalene synthase. A mechanism for the rearrangement of presqualene diphosphate to squalene. , 2002, Journal of the American Chemical Society.

[186]  Dong-Hyun Kim,et al.  Transformation of ginseng saponins to ginsenoside rh2 by acids and human intestinal bacteria and biological activities of their transformants , 2004, Archives of pharmacal research.

[187]  T. Dong,et al.  Simultaneous determination of 11 saponins in Panax notoginseng using HPLC-ELSD and pressurized liquid extraction. , 2006, Journal of separation science.

[188]  H. Yeung,et al.  The angiosuppressive effects of 20(R)- ginsenoside Rg3. , 2006, Biochemical pharmacology.

[189]  D. Vance,et al.  Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. , 2006, Vascular pharmacology.

[190]  I Saiki,et al.  An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. , 1998, Biochemical and biophysical research communications.

[191]  F. Song,et al.  Rapid identification of saponins in plant extracts by electrospray ionization multi-stage tandem mass spectrometry and liquid chromatography/tandem mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[192]  F. Song,et al.  Differentiation and identification of ginsenoside isomers by electrospray ionization tandem mass spectrometry , 2005 .

[193]  S. Yahara,et al.  Saponins of the Leaves of Panax ginseng C. A. MEYER , 1976 .

[194]  M. Kubo,et al.  Pharmacological study on Panax ginseng C. A. Meyer. IV. Effects of red ginseng on experimental disseminated intravascular coagulation. (3). Effect of ginsenoside-Ro on the blood coagulative and fibrinolytic system. , 1986, Chemical & pharmaceutical bulletin.

[195]  G. Bell,et al.  Anti-diabetic effect of ginsenoside Re in ob/ob mice. , 2005, Biochimica et biophysica acta.

[196]  G. Prestwich,et al.  ENZYMATIC CYCLIZATION OF SQUALENE AND OXIDOSQUALENE TO STEROLS AND TRITERPENES , 1993 .

[197]  S. Yahara,et al.  Degradation of ginseng saponins under mild acidic conditions. , 1982, Planta medica.

[198]  Zongwei Cai,et al.  A capsule review of recent studies on the application of mass spectrometry in the analysis of Chinese medicinal herbs. , 2002, Journal of mass spectrometry : JMS.

[199]  P. Eneroth,et al.  Gynostemma pentaphyllum: identification of major sapogenins and differentiation from Panax species. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[200]  J. H. Park,et al.  Liquid chromatographic determination of less polar ginsenosides in processed ginseng. , 2001, Journal of chromatography. A.

[201]  Lawrence A Leiter,et al.  American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. , 2001, The American journal of clinical nutrition.

[202]  Y. Shoyama,et al.  Formation of monoclonal antibody against a major ginseng component, ginsenoside Rg1 and its characterization. Monoclonal antibody for a ginseng saponin , 2000, Cytotechnology.

[203]  Lawrence A Leiter,et al.  Variable effects of American ginseng: a batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia , 2003, European Journal of Clinical Nutrition.

[204]  S. Reichlin Neuroendocrine-immune interactions. , 1993, The New England journal of medicine.

[205]  J. Sung,et al.  Main ginseng saponin metabolites formed by intestinal bacteria. , 1996, Planta medica.

[206]  M. Choo,et al.  Ginsenoside Rh1 Possesses Antiallergic and Anti-Inflammatory Activities , 2004, International Archives of Allergy and Immunology.

[207]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[208]  Q. K. Tran,et al.  Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity. , 2001, Journal of natural products.

[209]  B. McCarry,et al.  Characterization of ginseng saponins using electrospray mass spectrometry and collision-induced dissociation experiments of metal-attachment ions. , 2000, The Analyst.

[210]  S. O’Rahilly,et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.

[211]  Y. Nakaya,et al.  Involvement of Ca2+-Activated K+ Channels in Ginsenosides-Induced Aortic Relaxation in Rats , 2001, Journal of cardiovascular pharmacology.

[212]  Y. Lee,et al.  Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. , 1996, Cancer letters.

[213]  H. Matsuda,et al.  Medicinal flowers. XVII. New dammarane-type triterpene glycosides from flower buds of American ginseng, Panax quinquefolium L. , 2007, Chemical & pharmaceutical bulletin.

[214]  R. V. van Breemen,et al.  Use of high-performance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C. A. Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). , 2000, Analytical chemistry.

[215]  J. Bar-Tana,et al.  Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs. , 1995, The Journal of Biological Chemistry.

[216]  I. Tucker,et al.  High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[217]  G. Ren,et al.  Simultaneous quantification of ginsenosides in American ginseng (Panax quinquefolium) root powder by visible/near-infrared reflectance spectroscopy. , 1999, Journal of agricultural and food chemistry.

[218]  F. Soldati,et al.  Identification of ginsenosides from Panax ginseng in fractions obtained by high-performance liquid chromatography by field desorption mass spectrometry, multiple internal reflection infrared spectroscopy and thin-layer chromatography , 1981 .

[219]  J. Kwon,et al.  Application of the microwave-assisted process (MAP ) to the fast extraction of ginseng saponins , 2003 .

[220]  Libin Zhou,et al.  Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARγ2 and C/EBPα gene expression , 2007 .

[221]  D. Sohn,et al.  A dammarane glycoside from Korean red ginseng , 1997 .

[222]  Y. Ebizuka,et al.  In vitro conversion of 2,3-oxidosqualene into dammarenediol by Panax ginseng microsomes. , 1997, Biological & pharmaceutical bulletin.

[223]  W. Rausch,et al.  Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells , 2004, Journal of Neural Transmission.

[224]  Y. Bang,et al.  Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. , 2004, Carcinogenesis.

[225]  M. M. Anisimov,et al.  Triterpene glycosides from wild and cultivated ginseng occurring in maritime territory: Chemical characterization, comparative quantitative analysis, and biological activity study , 2000, Pharmaceutical Chemistry Journal.

[226]  R. V. van Breemen,et al.  Electrospray liquid chromatography/mass spectrometry of ginsenosides , 1995 .

[227]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[228]  W. Cho,et al.  Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. , 2006, European journal of pharmacology.

[229]  D. Dou,et al.  Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes. , 2005, Planta medica.

[230]  Shu Liu,et al.  Neuroprotective effects of ginsenosides. , 2006, Acta neurobiologiae experimentalis.

[231]  E. J. Staba,et al.  The ginsenosides of various ginseng plants and selected products. , 1980 .

[232]  S Odashima,et al.  Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells. , 1991, Journal of pharmaceutical sciences.

[233]  R. Kasai,et al.  Study on Saponins of Rhizomes of Panax pseudo-ginseng subsp. himalaicus Collected at Tzatogang and Pari-la, Bhutan-Himalaya , 1985 .

[234]  J. Cho,et al.  Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation. , 2002, Planta medica.

[235]  X. Wang,et al.  Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. by LC/MS/MS. , 1999, Analytical chemistry.

[236]  D. Kitts,et al.  Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco‐2 cells , 2004, Journal of biochemical and molecular toxicology.

[237]  L. K. Sørensen,et al.  Determination of marker constituents in radix Glycyrrhizae and radix Notoginseng by near infrared spectroscopy , 2000, Fresenius' journal of analytical chemistry.

[238]  Y. Shoyama,et al.  Identification and differentiation of Panax species using ELISA, RAPD and eastern blotting. , 2006, Phytochemical analysis : PCA.

[239]  M. Choo,et al.  Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. , 2002, Biological & pharmaceutical bulletin.

[240]  C. Yuan,et al.  Ginseng pharmacology: multiple constituents and multiple actions. , 1999, Biochemical pharmacology.

[241]  R. Kasai,et al.  Further Studies on Dammarane-Saponins of Sanchi-Ginseng , 1983 .

[242]  J. Shoji,et al.  Studies on the Constituents of Panacis Japonici Rhizoma. V. The Structures of Chikusetsusaponin I, Ia, Ib, IVa and Glycoside P1 , 1976 .

[243]  P. Eneroth,et al.  Alkaline cleavage of gypenosides and characterization of dammarane-type aglycones by gas chromatography–mass spectrometry , 1998 .

[244]  K. Kobashi,et al.  Drug Metabolism: Intestinal Bacterial Hydrolysis is Required for the Appearance of Compound K in Rat Plasma after Oral Administration of Ginsenoside Rb1 from Panax ginseng , 1998 .

[245]  S. Yahara,et al.  Dammarane saponins of leaves of Panax pseudo-ginseng subsp. himalaicus , 1978 .

[246]  Xueli Cao,et al.  Separation of Dammarane‐Saponins from Notoginseng, Root of Panax notoginseng (Burk.) F. H. Chen, by HSCCC Coupled with Evaporative Light Scattering Detector , 2003 .

[247]  M. Yoshikawa,et al.  Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes , 2005, BMC complementary and alternative medicine.

[248]  Y. Shoyama,et al.  Double staining of ginsenosides by Western blotting using anti-ginsenoside Rb1 and Rg1 monoclonal antibodies. , 2001, Biological & pharmaceutical bulletin.

[249]  Y. Benno,et al.  Role of Human Intestinal Prevotella oris in Hydrolyzing Ginseng Saponins , 1997, Planta medica.

[250]  P. Pietta,et al.  Improved high-performance liquid chromatographic method for the analysis of ginsenosides in Panax ginseng extracts and products. , 1986, Journal of chromatography.

[251]  Y. Yoo,et al.  Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. , 1995, Biological & pharmaceutical bulletin.

[252]  N. D. Kim,et al.  Dietary ginsenosides improve endothelium-dependent relaxation in the thoracic aorta of hypercholesterolemic rabbit. , 1995, General pharmacology.

[253]  J. Wen,et al.  A phylogenetic analysis ofPanax (Araliaceae): Integrating cpDNA restriction site and nuclear rDNA ITS sequence data , 2000, Plant Systematics and Evolution.

[254]  Jeong-Hill Park,et al.  Ginsenoside-Rs3, a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells. , 1999, Anticancer research.

[255]  H. Rhim,et al.  20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. , 2006, European journal of pharmacology.

[256]  O. Sticher,et al.  HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. 2nd communication. , 1980, Planta medica.

[257]  Armin Ruf,et al.  A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro , 2006 .

[258]  P. Eneroth,et al.  Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[259]  S. Chan,et al.  Overview on the analytical tools for quality control of natural product-based supplements: a case study of ginseng. , 2005, Assay and drug development technologies.

[260]  N. Chen,et al.  Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway , 2006, Brain Research.

[261]  S. Xu,et al.  A Pair of 24-hydroperoxyl Epimeric Dammarane Saponins from Flower-buds of Panax Ginseng , 2001, Journal of Asian natural products research.

[262]  D. Dou,et al.  Ginsenoside Rg8, a new dammarane-type triterpenoid saponin from roots of Panax quinquefolium. , 2006, Chemical & pharmaceutical bulletin.

[263]  J. Hendel,et al.  Influence of root age on the concentration of ginsenosides of American ginseng (Panax quinquefolium) , 1996 .

[264]  J. Auwerx,et al.  Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. , 1996, Atherosclerosis.

[265]  K. E. Malterud,et al.  Saponins from the roots of Panax notoginseng , 1999 .

[266]  A. Bilia,et al.  Analysis of plant complex matrices by use of nuclear magnetic resonance spectroscopy: St. John's wort extract. , 2001, Journal of agricultural and food chemistry.

[267]  T. Yun Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. , 2003, Mutation research.

[268]  J. Cui Identification and quantification of ginsenosides in various commercial ginseng preparations , 1995 .

[269]  K. Polonsky,et al.  Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. , 2002, Diabetes.

[270]  C. Nicol,et al.  Peroxisome proliferator‐activated receptor α is involved in the regulation of lipid metabolism by ginseng , 2003, British journal of pharmacology.

[271]  Z. Cai,et al.  High-performance liquid chromatography coupled with tandem mass spectrometry applied for metabolic study of ginsenoside Rb1 on rat. , 2006, Analytical biochemistry.

[272]  Y. Ahn,et al.  Inhibitory effect of ginsenoside on the mediator release in the guinea pig lung mast cells activated by specific antigen-antibody reactions. , 1998, International journal of immunopharmacology.

[273]  B. Gabetta,et al.  Liquid chromatography-electrospray mass spectrometric identification of ginsenosides in Panax ginseng roots. , 1999, Journal of chromatography. A.

[274]  H. Matsuda,et al.  Structures of Dammarane-Type Triterpene Triglycosides from the Flower Buds of Panax ginseng , 2007 .

[275]  Y. Shoyama,et al.  Enzyme‐Linked Immunosorbent Assay for the Determination of Total Ginsenosides in Ginseng , 2006 .

[276]  Sung-soo Kim,et al.  Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. , 2005, Biological & pharmaceutical bulletin.

[277]  Jeong-min Lee,et al.  Enzyme-linked immunosorbent assay for the determination of 20(S)-protopanaxatriol , 2002 .

[278]  D. Shangguan,et al.  New method for high-performance liquid chromatographic separation and fluorescence detection of ginsenosides. , 2001, Journal of chromatography. A.

[279]  Y. Ruan,et al.  Spatio‐Temporal Expression Pattern of Six Novel Candidate Genes in Ginsenoside Biosynthesis from Panax ginseng C. A. Meyer , 2005 .

[280]  Xiu Chen,et al.  CARDIOVASCULAR PROTECTION BY GINSENOSIDES AND THEIR NITRIC OXIDE RELEASING ACTION , 1996, Clinical and experimental pharmacology & physiology.

[281]  Soon-Cheol Ahn,et al.  Biotransformation of Korean Panax ginseng by Pectinex. , 2006, Biological & pharmaceutical bulletin.

[282]  I. Kitagawa,et al.  Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. , 1985, Cancer research.

[283]  Je-Jung Lee,et al.  Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization. , 2004, Biochemical pharmacology.

[284]  A. Der Marderosian,et al.  Studies on the constituents of dwarf ginseng , 1988 .

[285]  R. Kasai,et al.  New Dammarane Type Saponins of Leaves of Panax japonicus C.A. MEYER. (1). Chikusetsusaponins-L5, -L9a and -L10 , 1977 .

[286]  C. Yuan,et al.  Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. , 2002, The American journal of Chinese medicine.

[287]  Yi-nan Zheng,et al.  Isoginsenoside-Rh3, a new triterpenoid saponin from the fruits of Panax ginseng C. A. Mey , 2004, Journal of Asian natural products research.

[288]  S. Apers,et al.  Quantitative determination of ginsenosides from Panax ginseng roots and ginseng preparations by thin layer chromatography--densitometry. , 1999, Journal of pharmaceutical and biomedical analysis.

[289]  Dong-Hyun Kim,et al.  Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms. , 2005, Biological & pharmaceutical bulletin.

[290]  S. Kadota,et al.  Quinquenoside L9 from Leaves and Stems of Panax Quinquefolium L , 2001, Journal of Asian natural products research.

[291]  M. Vanhaelen,et al.  High-performance thin-layer chromatographic determination of six major ginsenosides in Panax ginseng. , 2000, Journal of chromatography. A.

[292]  Yongmoon Han,et al.  Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell. , 2006, International immunopharmacology.

[293]  Xinmiao Liang,et al.  Identification of ginsenosides in roots of Panax ginseng by HPLC-APCI/MS. , 2005, Phytochemical analysis : PCA.

[294]  R. Kasai,et al.  Ginsenoside-Ra1 and Ginsenoside-Ra2, New Dammarane-Saponins of Ginseng Roots , 1982 .

[295]  H. Matsuda,et al.  Bioactive saponins and glycosides. XI. Structures of new dammarane-type triterpene oligoglycosides, quinquenosides I, II, III, IV, and V, from American ginseng, the roots of Panax quinquefolium L. , 1998, Chemical & pharmaceutical bulletin.

[296]  Shin-Jeong Lee,et al.  20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. , 2006, Biochemical and biophysical research communications.

[297]  L. P. Christensen,et al.  Bioactive polyacetylenes in food plants of the Apiaceae family: occurrence, bioactivity and analysis. , 2006, Journal of pharmaceutical and biomedical analysis.

[298]  H. J. Park,et al.  Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. , 1996, Biological & pharmaceutical bulletin.

[299]  Y. Shoyama,et al.  A one-step immunochromatographic assay for detecting ginsenosides Rb1 and Rg1 , 2004, Analytical and Bioanalytical Chemistry.

[300]  W. Li,et al.  Determination of 24(R)-pseudoginsenoside F(11) in North American ginseng using high performance liquid chromatography with evaporative light scattering detection. , 2001, Journal of pharmaceutical and biomedical analysis.

[301]  Cuk-Seong Kim,et al.  Effect of Korea red ginseng on cerebral blood flow and superoxide production. , 2002, Acta pharmacologica Sinica.

[302]  B. Aggarwal,et al.  Nuclear factor-kappa B and cancer: its role in prevention and therapy. , 2002, Biochemical pharmacology.

[303]  C. Yuan,et al.  American ginseng leaf: ginsenoside analysis and hypoglycemic activity. , 2004, Pharmacological research.

[304]  H. Suh,et al.  The inhibitory effect of ginseng saponins on the stress-induced plasma interleukin-6 level in mice , 2003, Neuroscience Letters.

[305]  E. Perry The cholinergic hypothesis--ten years on. , 1986, British medical bulletin.

[306]  Y. Shoyama,et al.  Applications of ELISA, western blotting and immunoaffinity concentration for survey of ginsenosides in crude drugs of Panax species and traditional Chinese herbal medicines. , 2000, The Analyst.

[307]  S. Sheu,et al.  A comparative study on commercial samples of ginseng radix. , 1995, Planta medica.

[308]  Shanshan Wang,et al.  High-performance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues. , 2006, Biomedical chromatography : BMC.

[309]  M. Kubo,et al.  Simultaneous Analysis of Saponins in Ginseng Radix by High Performance Liquid Chromatography , 1995 .

[310]  E. Seo,et al.  20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. , 2004, Cancer letters.

[311]  Hongxiang Sun,et al.  Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng. , 2006, International immunopharmacology.

[312]  Y. Takino,et al.  Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat. , 1983, Chemical & pharmaceutical bulletin.

[313]  H. Robertson,et al.  Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease , 2003, Experimental Neurology.

[314]  Masaaki Kuwabara,et al.  Dammarane Saponins of Gynostemma pentaphyllum MAKINO and Isolation of Malonylginsenosides-Rb1, -Rd, and Malonylgypenoside V , 1989 .

[315]  K. Oh,et al.  Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. , 1994, General pharmacology.

[316]  G. Tan,et al.  Polyacetyleneginsenoside-Ro, a novel triterpene saponin from Panax ginseng , 2002 .

[317]  Jeong-Hill Park,et al.  Ginsenoside Rs3, a genuine dammarane-glycoside from Korean red ginseng , 1996, Archives of pharmacal research.

[318]  B. Min,et al.  Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1/Th2 differentiation. , 2004, International immunopharmacology.